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Introduction 
Chronic critical ower limb ischaemia (CLI) is common 
and has a major impact on the use of hospital 
resources. Recent reports have identified that there are 
deficiencies in the delivery of care to patients with this 
condition. 1-4 The aim of this document is to discuss 
the present management of CLI and make recom- 
mendations for optimising care so that amputation 
rates are kept to a minimum and the best use made of 
the limited resources available for health care. 
Although chronic ischaemia of a leg can occur for a 
number of different reasons the following discussion 
will focus on the most frequent cause of this condition: 
occlusive arterial disease due to atherosclerosis. 
This paper is based on the results of a national audit 
of CLI undertaken by the Audit Committee of the 
Vascular Surgical Society of Great Britain and 
Ireland. 4
Definition 
Attempts have been made to define CLI 5'6 based on 
the measurement of ankle systolic blood pressure, 
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tissue loss and presence of rest pain. Unfortunately 
recent evidence has shown that definitions based on 
arbitrary blood pressure measurements have little 
clinical relevance 7 and no definition of CLI can predict 
which diabetics will require amputation. 8 Thus CLI is 
defined clinically as chronic or acute-on-chronic 
ischaemia that endangers the whole or part of a leg. 
Acute leg ischaemia, due to arterial embolism or 
thrombosis, is not the subject of this document as it 
will be the subject of another national audit. 
Incidence/prevalence 
Accurate figures on the frequency with which CLI is 
encountered are not available. The Second European 
Consensus Document on Chronic Critical Limb 
Ischaemia 6 estimated the incidence to be 50-100 per 
100 000 per year, in Scandinavia the incidence is 60-80 
per 100 000, 9 whereas recent data from Oxford 1 sug- 
gests an incidence of 30 per 100 000 per year. From the 
national audit, the Vascular Surgical Society 4 has 
estimated that there are 20 000 patients presenting 
annually in the U.K. and Ireland equating to 40 per 
100 000 per year. Allowing for some inaccuracy in this 
latter estimation, CLI is clearly generating a consider- 
able workload for the health services of Great Britain 
and Ireland and therefore consuming a significant 
amount of health care resources. 
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Clinical 
CLI is more common in men than women (M:F = 
1.48:1), but over the age of 80 years equal numbers 
of men and women are affected. The peak age 
incidence is between 70 and 79 years. A third of 
patients have diabetes. 4 
The majority of patients develop chronic CLI with 
symptoms for some days, or weeks, consisting of 
rest pain with or without associated ulceration and 
gangrene. Occasionally ulceration or gangrene may 
be present without pain, usually in diabetics. The 
national audit shows that one-third of these patients 
will have had symptoms for less than a week, and 
half for 3 or more weeks. 4 Rest pain is a presenting 
symptom in 74%, gangrene in 34% and ulceration in 
32%. 
Patients with CLI have a high risk of dying with a 
mortality in excess of 10% per annum, 8'l°-az usually 
from other associated cardiovascular disease. 
Management 
For acute leg ischaemia, immediate intervention is 
needed to save the leg whereas for chronic CLI 
treatment can usually be delayed for a few days, but 
this still means patients require urgent management 
to relieve the distress of rest pain or progression to 
gangrene. Delays in referral investigation and treat- 
ment can jeopardise the chances of saving a leg. 6 
Therefore all patients with chronic CLI must be 
admitted urgently, 6 they should not be placed on 
waiting lists, and investigation and treatment should 
be carried out as soon as possible after admission. 
For the majority of patients, with a potentially 
viable limb, the aim of treatment is avoid amputa- 
tion by revascularising the leg. 1B When a patient has 
a leg which is not viable, or the prospects of 
subsequent mobilisation and returning to an inde- 
pendent existence are not good, then primary ampu- 
tation may be the best course of action. For a few 
individuals who are not fit for surgical treatment, 
analgesia nd nursing care will be more appropriate. 
The national audit 4 reveals that 66% of patients 
admitted to hospital undergo revascularisation, 16% 
primary major amputation, 10% medical or minor 
surgical treatment and 8% symptomatic relief only. 
Two thirds of revascularisation are bypass grafts and 
one third percutaneous transluminal angioplasty or 
thrombolysis. Limb salvage is achieved in 68% with 
a major amputation rate (primary amputation and 
failed reconstruction) of 22%. Diabetics are less 
likely to undergo reconstruction (55%) with a lower 
rate of limb salvage (60%). 
These patients often have intercurrent medical 
problems, particularly ischaemic heart disease and 
diabetes. Collaboration between physicians, anaes- 
thetists and physiotherapists a well as surgeons and 
radiologists is needed if the patients are to be made 
fit for treatment and the best outcomes obtained. 
The management of CLI therefore requires a team 
approach. 6 
Angiography is necessary before deciding on what 
form of revascularisation is appropriate to an indi- 
vidual patient. However, conventional angiography 
does not always demonstrate the distal vessels of 
the leg, but this does not mean that none are 
available for a bypass graft. 14 The use of digital 
vascular imaging can improve visualisation of the 
distal vessels, hand held Doppler 15 and pulse gen- 
erated run off 16 can help in assessing operability and 
in theatre on-table angiography 17and measurement 
of peripheral resistance 18can also help decide on the 
suitability of proceeding with a graft. 
Although some patients need angioplasty or sur- 
gery to the proximal vessels of the leg, a quarter will 
need grafting to the popliteal artery below the knee 
and nearly a third to the tibial and peroneal vessels 
or foot. 4 Results from bypasses to the calf are now 
recognised as being sufficiently good to justify these 
long and difficult operations 19-23 and there is now 
some evidence that taking grafts onto the foot is 
worthwhile. 23-28 Autologous vein is the preferred 
conduit for infrainguinal bypass grafts. 12'29-32 Pre- 
operative Duplex ultrasound of the long saphenous 
vein 33 can be used to decide if the vein is suitable 
and mark its position on the leg. Postoperative 
surveillance with ultrasound will improve 
results. 22'34'35 Should the long saphenous vein not be 
available then the insertion of vein patches 36 and 
CLIffS 37'38 at the distal anastomosis can improve the 
patency of synthetic grafts and arm veins can also 
be considered as an alternative. 39
Following amputation it is important hat there is 
ready access to limb fitting and other rehabilitation 
services. Many amputees fail to walk again 13'4°'4~ 
and often become isolated within their own homes. 4~ 
Attention has therefore to be focused not only on 
walking training but also rehabilitation into the 
community. 41
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Outcome 
The majority of patients are treated either by revas- 
cularisation or amputation. When these two alter- 
natives are compared patients who have had revas- 
cularisation stay in hospital half as long, are less 
likely to die and are more likely to be discharged 
home than are patients having amputations. 4'42 Fur- 
thermore, a person with a reconstructed leg has 
better prospects for surviving during the ensuing 
years 43 and amputees often fail to achieve mobility 
and frequently need long term institutional care. 13"44 
However patient selection may be responsible for 
some of these differences and no randomised trial of 
bypass grafting versus amputation has been 
performed. 
The amount of work undertaken by a surgeon 
may also influence outcome. The national audit 
reveals that legs are more likely to be saved and the 
method of salvage more likely to include some form 
of radiological intervention if a surgeon undertakes 
more than 10 femorodistal bypasses annually. 4 One 
explanation is that these surgeons are more spe- 
cialised, and because they tend to work in larger 
centres, have more facilities available to them. 
Recent analysis of health trends also indicates that 
in areas with high rates of distal arterial reconstruc- 
tion there are fewer amputations 4 '46 and those 
amputations that are carried out are at a more distal 
level and more likely to be preceded by attempts to 
salvage the leg. 45 
Social and Economic Consequences 
Successful revascularisation can be complex and 
time consuming but is to be preferred to amputation 
since it results in a better quality of life, 47-sl shorter 
hospital stay 4'42 and more patients being discharged 
home, 4'42 even in the very elderly. 13'22'4~'43"51's2 Limb 
salvage is also more cost-effective than amputa- 
tion. 1"4'13'44's0'51'53-56 Operations for CLI probably 
account for half of all vascular econstructive proce- 
dures 4'57 and the high prevalence of this condition 
thus places an enormous burden on health services. 
It is therefore important that treatment for these 
patients is optimised so the best outcomes are 
achieved within the limited resources available. 9 
Organisation of surgical services 
Although there is evidence that the overall quality of 
care in Great Britain and Ireland to patients with CLI 
is generally of a high standard 4 there remain areas of 
concern. Deciding what treatment is appropriate to an 
individual patient can be difficult and therefore no 
patient with CLI should be treated without an expert 
vascular opinion, which should be available at all 
times. 2'58 Management of this condition is not some- 
thing for the occasional vascular surgeon. Outcomes 
are thought to be better when surgeons are dealing 
these patients on a regular basis 4 and thus surgeons 
looking after these patients hould either be full time 
vascular surgeons or general surgeons with a major 
vascular interest. When surgery is combined with 
modern radiological facilities most limbs can be 
revascularised and this should be attempted wherever 
possible and appropriate. ~3"s9 
To avoid lengthy delays for operations and prevent 
long complex procedures being undertaken out of 
hours 6° an emergency theatre should be available ~
during the working day. In major centres, a theatre 
dedicated to vascular surgery might be a better option. 
There should also be access to a vascular laboratory 
and urgent radiological investigation and treatment. 
Since radiological intervention sometimes fails to re- 
establish the blood supply to a limb and occasionally 
has complications needing surgical intervention cover 
from a vascular surgeon should be agreed before 
interventional procedures are undertaken. 
Should vascular surgeons work single-handedly? 
The evidence suggests that patients with CLI are 
likely to have the best chance of limb salvage if 
treated in large well equipped multidisciplinary vas- 
cular urtits. 1'4 A single-handed surgeon cannot 
always be available or expected to be continuously 
on-call to treat these difficult and urgent 
patientsY '6° A surgeon working alone may not be 
supported by a radiology department able to pro- 
vide emergency angiographic and interventional 
facilities and may fail to provide sufficient numbers 
of patients to justify the expense of installing up to 
date and expensive radiological equipment. 61 Fur- 
thermore, a single handed surgeon may not have the 
opportunity to discuss patients with colleagues to 
determine the best course of management, and may 
lack the specialist workload to maintain expertise. 6 
Thus single handed surgeons hould be encouraged 
to collaborate or the service concentrated into fewer 
hospitals. 3"4 In practice, continuous on-call cover 
requires 3-4 vascular surgeons and a similar number 
of interventional radiologists. 
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Recommendations 
1. Patients with chronic critical ower limb ischae- 
mia should be admitted, investigated and treated 
urgently. 
2. Access to angiography and vascular laboratory 
assessment should be available within 24 h. 
3. Access to an operating theatre and interventional 
radiology should be available within 24 h, 
preferably during the normal working day. 
4. No patient with chronic critical lower limb 
ischaemia should be treated without an expert 
vascular opinion which should be available at all 
times. 
5. Revascularisation should be attempted wherever 
possible and appropriate. 
6. Before interventional radiological procedures are 
undertaken, cover from a vascular surgeon 
should be agreed. 
7. Patients who require amputation should have 
rapid access to co-ordinated rehabilitation and 
limb fitting services. 
Implications 
(i) The optimal management of chronic critical 
lower limb ischaemia requires sufficient consult- 
ant vascular surgeons and interventional radi- 
ologists to be able to provide continuous on-call 
cover. 
(ii) A high throughput of patients is required to 
maintain expertise and to make efficient use of 
the expensive resources required for the manage- 
ment of chronic critical lower limb ischaemia. 
(iii) Achievement of these goals will require either 
closer collaboration between units or concentra- 
tion of the service into fewer hospitals. 
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